Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Infectious Disease Reports
Published in: Current Infectious Disease Reports 6/2012

01-12-2012 | Healthcare-Associated Infections (G Bearman and M Stevens, Section Editors)

Staphylococcus aureus Bacteriuria: Source, Clinical Relevance, and Management

Authors: Mayar Al Mohajer, Rabih O. Darouiche

Published in: Current Infectious Disease Reports | Issue 6/2012

Login to get access

Abstract

Staphylococcus aureus bacteriuria is a common condition with still largely undetermined clinical relevance. Although S. aureus bacteriuria can be secondary to bacteremia and systemic infection in some patients, it may predispose to bacteremia and invasive disease in others. Whereas most patients with S. aureus bacteriuria do not have symptomatic urinary tract infection, it is reportedly associated with endocarditis and other types of invasive diseases, thereby resulting in major morbidity and occasional mortality. This review summarizes and analyzes the results of previous reports of S. aureus bacteriuria and assesses the clinical relevance and management of this increasingly recognized entity.
Literature
1.
•• Baraboutis IG, Tsagalou EP, Lepinski JL, et al. Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract. Eur J Clin Microbiol Infect Dis. 2010;29(9):1095–101. This paper highlights different risk factors for the developement of Staphylococcus aureus urinary tract infections.PubMedCrossRef
2.
•• Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O. Clinical significance of Staphylococcus aureus bacteriuria in a nationwide study of adults with S. aureus bacteremia. J Infect. 2012;64(1):41–6. This paper is important since it provides very important information about the significance of Staphylococcus aureus bacteriuria.PubMedCrossRef
3.
Muder RR, Brennen C, Rihs JD, et al. Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia. Clin Infect Dis. 2006;42(1):46–50.PubMedCrossRef
4.
Routh JC, Alt AL, Ashley RA, et al. Increasing prevalence and associated risk factors for methicillin resistant Staphylococcus aureus bacteriuria. J Urol. 2009;181(4):1694–8.PubMedCrossRef
5.
Arpi M, Renneberg J. The clinical significance of Staphylococcus aureus bacteriuria. J Urol. 1984;132(4):697–700.PubMed
6.
Lee BK, Crossley K, Gerding DN. The association between Staphylococcus aureus bacteremia and bacteriuria. Am J Med. 1978;65(2):303–6.PubMedCrossRef
7.
Coll PP, Crabtree BF, O'Connor PJ, Klenzak S. Clinical risk factors for methicillin-resistant Staphylococcus aureus bacteriuria in a skilled-care nursing home. Arch Fam Med. 1994;3(4):357–60.PubMedCrossRef
8.
Demuth PJ, Gerding DN, Crossley K. Staphylococcus aureus bacteriuria. Arch Intern Med. 1979;139(1):78–80.PubMedCrossRef
9.
Ekkelenkamp MB, Verhoef J, Bonten MJ. Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital. Clin Infect Dis. 2007;44(11):1457–9.PubMedCrossRef
10.
• Chihara S, Popovich KJ, Weinstein RA, Hota B. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study. BMC Infect Dis. 2010;10:225. This paper highlights the role of Staphylococcus aureus bacteriuria as a prognostic factor in patients with S. aureus bacteremia.PubMedCrossRef
11.
•• Perez-Jorge EV, Burdette SD, Markert RJ, Beam WB. Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortality. J Hosp Med. 2010;5(4):208–11. This paper highlights the association between Staphylococcus aureus bacteriuria and mortality in patients with S. aureus bacteremia.PubMedCrossRef
12.
Huggan PJ, Murdoch DR, Gallagher K, Chambers ST. Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteremia. J Hosp Infect. 2008;69(4):345–9.PubMedCrossRef
13.
Flournoy DJ. A descriptive analysis of urine cultures: pure versus mixed isolates. Mil Med. 1992;157(10):514–8.PubMed
14.
Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Epidemiological and clinical characteristics of methicillin sensitive Staphylococcus aureus (MSSA) bacteriuria. J Infect. 2009;58(2):119–22.PubMedCrossRef
15.
Anderson DJ, Kaye KS, Sexton DJ. Methicillin-resistant Staphylococcus aureus bacteremia after isolation from urine. Clin Infect Dis. 2006;42(10):1504–5.PubMedCrossRef
16.
Puri J, Mishra B, Mal A, et al. Catheter associated urinary tract infections in neurology and neurosurgical units. J Infect. 2002;44(3):171–5.PubMedCrossRef
17.
Sapico FL, Montgomerie JZ, Canawati HN, Aeilts G. Methicillin-resistant Staphylococcus aureus bacteriuria. Am J Med Sci. 1981;281(2):101–9.PubMedCrossRef
18.
Sheth S, DiNubile MJ. Clinical significance of Staphylococcus aureus bacteriuria without concurrent bacteremia. Clin Infect Dis. 1997;24(6):1268–9.PubMedCrossRef
19.
Sullivan NM, Sutter VL, Carter WT, et al. Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems. Appl Microbiol. 1972;23(6):1101–6.PubMed
20.
Sullivan NM, Sutter VL, Mims MM, et al. Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis. 1973;127(1):49–55.PubMedCrossRef
21.
• Pulcini C, Matta M, Mondain V, et al. Concomitant Staphylococcus aureus bacteriuria is associated with complicated S. aureus bacteremia. J Infect. 2009;59(4):240–6. This paper highlights the association between Staphylococcus aureus bacteriuria and complicated S. aureus bacteremia.PubMedCrossRef
22.
• Choi SH, Lee SO, Choi JP, et al. The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia. J Infect. 2009;59(1):37–41. This paper highlights the association between Staphylococcus aureus bacteriuria and vertebral osteomeylitis.PubMedCrossRef
23.
Nesbit RN, Dick VS. Acute staphylococcal infections of the kidney. J Urol. 1940;43:623.
24.
Gorrill RH. The establishment of staphylococcal abscesses in the mouse kidney. Br J Exp Pathol. 1958;39:203.PubMed
25.
De Navasquez S. Experimental pyelonephritis in the rabbit produced by staphylococcal infection. J Pathol Bacteriol. 1950;62(3):429–36.PubMedCrossRef
26.
Genster HG, Andersen MJ. Spinal osteomyelitis complicating urinary tract infection. J Urol. 1972;107(1):109–11.PubMed
27.
Metadata
Title
Staphylococcus aureus Bacteriuria: Source, Clinical Relevance, and Management
Authors
Mayar Al Mohajer
Rabih O. Darouiche
Publication date
01-12-2012
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 6/2012
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-012-0290-4

Other articles of this Issue 6/2012

Current Infectious Disease Reports 6/2012 Go to the issue

Healthcare-Associated Infections (G Bearman and M Stevens, Section Editors)

Health-Care Worker Vaccination for Influenza: Strategies and Controversies

Healthcare-Associated Infections (G Bearman and M Stevens, Section Editors)

Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures

Transplant and Oncology (MG Ison, Section Editor)

Emerging Parasitic Infections in Transplantation

Healthcare-Associated Infections (G Bearman and M Stevens, Section Editors)

Antimicrobial Stewardship as Part of the Infection Prevention Effort

Healthcare-Associated Infections (G Bearman and M Stevens, Section Editors)

Blood and Body Fluid Exposures in Health-Care Settings: Risk Reduction Practices and Postexposure Prophylaxis for Health-Care Workers

Transplant and Oncology (MG Ison, Section Editor)

Donor-Derived Infection: Epidemiology and Outcomes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits